Updated bioavailability and 48 h excretion profile of flavan-3-ols from green tea in humans

References

• Appeldoorn MM, Vincken JP, Aura AM, Hollman PC, Gruppen H. 2009. Procyanidin dimers are metabolized by human microbiota with 2-(3,4-dihydroxyphenyl)acetic acid and 5-(3,4-dihydroxyphenyl)-gamma-valerolactone as the major metabolites. J Agric Food Chem. 57 3: 1084–1092.
   PubMed Web of Science ®Google Scholar
• Auger C, Mullen W, Hara Y, Crozier A. 2008. Bioavailability of polyphenon E flavan-3-ols in humans with an ileostomy. J Nutr. 138 8: 1535S–1542S.
   Google Scholar
• Cabrera C, Artacho R, Giménez R. 2006. Beneficial effects of green tea – a review. J Am Coll Nutr. 25 2: 79–99 Review.
   PubMed Web of Science ®Google Scholar
• Chow HH, Hakim IA, Vining DR, Crowell JA, Ranger-Moore J, Chew WM, . 2005. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin Cancer Res. 11 12: 4627–4633.
   PubMed Web of Science ®Google Scholar
• Coughtrie MW, Johnston LE. 2001. Interactions between dietary chemicals and human sulfotransferases-molecular mechanisms and clinical significance. Drug Metab Dispos. 29 4 Pt 2: 522–528.
   PubMedGoogle Scholar
• Crozier A, Del Rio D, Clifford MN. 2010. Bioavailability of dietary flavonoids and phenolic compounds. Mol Aspects Med. 31 6: 446–467.
   PubMed Web of Science ®Google Scholar
• Del Rio D, Borges G, Crozier A. Berry flavonoids and phenolics: bioavailability and evidence of protective effects. Br J Nutr. 2010a; 104 Suppl 3: S67–S90.
   PubMed Web of Science ®Google Scholar
• Del Rio D, Calani L, Cordero C, Salvatore S, Pellegrini N, Brighenti F. Bioavailability and catabolism of green tea flavan-3-ols in humans. Nutrition. 2010b; 26 11–12: 1110–1116.
   PubMed Web of Science ®Google Scholar
• Donovan JL, Manach C, Fauks RM, Kroon PA. 2006. Absorption and metabolism of dietary plant secondary metabolites. In: Crozier A, Clifford MN, Ashihara H. editors. Plant secondary metabolites: occurrence, structure and role in the human diet. Oxford: Blackwell Publishing303–351.
   Google Scholar
• Düweler KG, Rohdewald P. 2000. Urinary metabolites of French maritime pine bark extract in humans. Pharmazie. 55 5: 364–368.
   PubMedGoogle Scholar
• Henning SM, Niu Y, Liu Y, Lee NH, Hara Y, Thames GD, . 2005. Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individuals. J Nutr Biochem. 16 10: 610–616.
   PubMed Web of Science ®Google Scholar
• Kalili KM, de Villiers A. 2010. Off-line comprehensive two-dimensional hydrophilic interaction × reversed phase liquid chromatographic analysis of green tea phenolics. J Sep Sci. 33 6–7: 853–863.
   PubMed Web of Science ®Google Scholar
• Knights KM, Miners JO. 2010. Renal UDP-glucuronosyltransferases and the glucuronidation of xenobiotics and endogenous mediators. Drug Metab Rev. 42 1: 63–73.
   PubMed Web of Science ®Google Scholar
• Kuriyama S. 2008. The relation between green tea consumption and cardiovascular disease as evidenced by epidemiological studies. J Nutr. 138 8: 1548S–1553S Review.
   PubMed Web of Science ®Google Scholar
• Lambert JD, Sang S, Yang CS. 2007. Biotransformation of green tea polyphenols and the biological activities of those metabolites. Mol Pharm. 4 6: 819–825.
   PubMed Web of Science ®Google Scholar
• Lee MJ, Maliakal P, Chen L, Meng X, Bondoc FY, Prabhu S, . 2002. Pharmacokinetics of tea catechins after ingestion of green tea and ( − )-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev. 11 10 Pt 1: 1025–1032.
   PubMed Web of Science ®Google Scholar
• Li C, Lee MJ, Sheng S, Meng X, Prabhu S, Winnik B, . 2000. Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chem Res Toxicol. 13 3: 177–184.
   PubMed Web of Science ®Google Scholar
• Lin LZ, Chen P, Harnly JM. 2008. New phenolic components and chromatographic profiles of green and fermented teas. J Agric Food Chem. 56 17: 8130–8140.
   PubMed Web of Science ®Google Scholar
• Llorach R, Garrido I, Monagas M, Urpi-Sarda M, Tulipani S, Bartolome B, Andres-Lacueva C. 2010. Metabolomics study of human urinary metabolome modifications after intake of almond (Prunus dulcis (Mill.) D.A. Webb) skin polyphenols. J Proteome Res. 9 11: 5859–5867.
   PubMedGoogle Scholar
• Manach C, Williamson G, Morand C, Scalbert A, Rémésy C. 2005. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr. 81 1 Suppl: 230S–242S.
   PubMed Web of Science ®Google Scholar
• Mandel SA, Amit T, Kalfon L, Reznichenko L, Youdim MB. 2008. Targeting multiple neurodegenerative diseases etiologies with multimodal-acting green tea catechins. J Nutr. 138 8: 1578S–1583S.
   PubMed Web of Science ®Google Scholar
• Mullen W, Edwards CA, Crozier A. 2006. Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions. Br J Nutr. 96 1: 107–116.
   PubMedGoogle Scholar
• Mullen W, Archeveque MA, Edwards CA, Matsumoto H, Crozier A. 2008. Bioavailability and metabolism of orange juice flavanones in humans: impact of a full-fat yogurt. J Agric Food Chem. 56 23: 11157–11164.
   PubMed Web of Science ®Google Scholar
• Roowi S, Stalmach A, Mullen W, Lean ME, Edwards CA, Crozier A. 2010. Green tea flavan-3-ols: colonic degradation and urinary excretion of catabolites by humans. J Agric Food Chem. 58 2: 1296–1304.
   PubMed Web of Science ®Google Scholar
• Sang S, Lee MJ, Yang I, Buckley B, Yang CS. 2008. Human urinary metabolite profile of tea polyphenols analyzed by liquid chromatography/electrospray ionization tandem mass spectrometry with data-dependent acquisition. Rapid Commun Mass Spectrom. 22 10: 1567–1578.
   PubMedGoogle Scholar
• Selma MV, Espín JC, Tomás-Barberán FA. 2009. Interaction between phenolics and gut microbiota: role in human health. J Agric Food Chem. 57 15: 6485–6501.
   PubMed Web of Science ®Google Scholar
• Stalmach A, Troufflard S, Serafini M, Crozier A. 2009. Absorption, metabolism and excretion of Choladi green tea flavan-3-ols by humans. Mol Nutr Food Res. 53 Suppl 1: S44–S53.
   Google Scholar
• Stalmach A, Mullen W, Steiling H, Williamson G, Lean ME, Crozier A. 2010. Absorption, metabolism, and excretion of green tea flavan-3-ols in humans with an ileostomy. Mol Nutr Food Res. 54 3: 323–334.
   PubMedGoogle Scholar
• Stoupi S, Williamson G, Drynan JW, Barron D, Clifford MN. 2010. A comparison of the in vitro biotransformation of ( − )-epicatechin and procyanidin B2 by human faecal microbiota. Mol Nutr Food Res. 54 6: 747–759.
   PubMedGoogle Scholar
• Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK. 2007. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett. 245 1–2: 232–241.
   PubMedGoogle Scholar
• Tukey RH, Strassburg CP. 2000. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol. 40:581–616.
   PubMed Web of Science ®Google Scholar
• Zaveri NT. 2006. Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications. Life Sci. 78 18: 2073–2080 Epub 2006 Jan 30. Review.
   PubMed Web of Science ®Google Scholar